$IMVT Immunovant, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Immunovant, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Immunovant, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Immunovant, Inc. for free.
IRS Number: 832771572
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: IMVT
Company Address: 320 WEST 37TH STREET NEW YORK 10018
Former name: Health Sciences Acquisitions Corp, date of change: 2019-01-08
Immunovant, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | IMVT | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Grant | A | 0.00 | 15,500 | 0 | 60,200 | 44.7 K to 60.2 K (+34.68 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Torti Frank | Director | Option Exercise | A | 17.00 | 28,900 | 491,300 | 28,900 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Torti Frank | Director | Grant | A | 0.00 | 19,200 | 0 | 47,600 | 28.4 K to 47.6 K (+67.61 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Pande Atul | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Pande Atul | Director | Grant | A | 0.00 | 15,500 | 0 | 40,200 | 24.7 K to 40.2 K (+62.75 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Director | Grant | A | 0.00 | 15,500 | 0 | 40,200 | 24.7 K to 40.2 K (+62.75 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Director | Grant | A | 0.00 | 15,500 | 0 | 40,200 | 24.7 K to 40.2 K (+62.75 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Off ... | Option Exercise | A | 17.00 | 464,700 | 7,899,900 | 464,700 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Off ... | Grant | A | 0.00 | 132,500 | 0 | 132,500 | 0 to 132.5 K |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Yanchik Connealy Pamela | Chief Financial Off ... | Option Exercise | A | 17.00 | 162,000 | 2,754,000 | 162,000 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Yanchik Connealy Pamela | Chief Financial Off ... | Grant | A | 0.00 | 46,200 | 0 | 46,200 | 0 to 46.2 K |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Elliott Michael James | Chief Scientific Of ... | Option Exercise | A | 17.00 | 342,300 | 5,819,100 | 342,300 |